Home › Funds › Steadfast Capital Management › WST
Steadfast Capital Management position in WST
WEST PHARMACEUTICAL SVSC INC · Health Care
Latest position (Q4 2025)429.91K sh
Reported value held$118.28M
Portfolio Weight2.03%
First reportedQ3 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 471.42K | $123.67M | New |
| Q4 2025 | 429.91K | $118.28M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding WST
- Vanguard Group 9.54M sh · $2.62B · Q4 2025
- BlackRock Inc 6.65M sh · $2.39B · Q2 2026
- Fidelity Management & Research (FMR) 3.57M sh · $1.28B · Q2 2026
- BNY Mellon 2.04M sh · $733.73M · Q2 2026
- Geode Capital Management 1.90M sh · $680.55M · Q2 2026
- Morgan Stanley 1.58M sh · $568.14M · Q2 2026
- JPMorgan Chase & Co 1.16M sh · $413.03M · Q2 2026
- Invesco Ltd 1.01M sh · $362.54M · Q2 2026
- Norges Bank Investment Management 862.91K sh · $309.79M · Q2 2026
- Goldman Sachs Group 814.77K sh · $292.50M · Q2 2026
- Northern Trust Corp 709.42K sh · $254.68M · Q2 2026
- Capital Research Global Investors 609.22K sh · $218.71M · Q2 2026